<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D8B0F01C-87D9-453B-B630-74B452BD6B29"><gtr:id>D8B0F01C-87D9-453B-B630-74B452BD6B29</gtr:id><gtr:name>Sepsis Limited</gtr:name><gtr:address><gtr:line1>35 Beaconsfield Road</gtr:line1><gtr:city>Liverpool</gtr:city><gtr:postCode>L25 6EQ</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D8B0F01C-87D9-453B-B630-74B452BD6B29" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>D8B0F01C-87D9-453B-B630-74B452BD6B29</gtr:id><gtr:name>Sepsis Limited</gtr:name><gtr:address><gtr:line1>35 Beaconsfield Road</gtr:line1><gtr:city>Liverpool</gtr:city><gtr:postCode>L25 6EQ</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>15026.0</gtr:offerGrant><gtr:projectCost>112500.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>83887.0</gtr:offerGrant><gtr:projectCost>111850.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB0D823-3562-42DE-9E8D-2F0689AE2D64" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>2DB0D823-3562-42DE-9E8D-2F0689AE2D64</gtr:id><gtr:name>L3 Technology Limited</gtr:name><gtr:address><gtr:line1>THE ELMS COURTYARD, BROMSBERROW , LEDBURY</gtr:line1><gtr:city>HEREFORDSHIRE</gtr:city><gtr:postCode>HR8 1RZ</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>8974.0</gtr:offerGrant><gtr:projectCost>17948.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A232E354-7155-42BE-94EA-947529415055"><gtr:id>A232E354-7155-42BE-94EA-947529415055</gtr:id><gtr:firstName>Grants</gtr:firstName><gtr:surname>Team</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=130253"><gtr:id>66F97149-CD41-4655-AA37-86ADBCE56564</gtr:id><gtr:title>Rapid Point of Care Detection of Bacterial Sepsis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>130253</gtr:grantReference><gtr:abstractText>Project title: Rapid Point of Care detection of Bacterial Sepsis
Project outline: This project aims to deliver a hand held prototype device for the diagnosis of sepsis within 3 minutes sampling. The assay detects changes before classical sepsis diagnosis and this has been shown in children and adults in settings that include the emergency room, post-surgery, oncology and intensive care settings. It will be coupled with a new bespoke hand held device to deliver a test result from a 'pin-prick' of blood, allowing bed-side use from sample to result. The result will be either qualitative for diagnosis (Yes/No) or quantitative for repeated use in subsequent therapy monitoring. The product that will be developed will be the only true point-of-care device for the diagnosis and prognosis of bacterial sepsis on the market.</gtr:abstractText><gtr:fund><gtr:end>2012-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2011-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>107887</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">130253</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>